Home › Funds › BVF INC/IL › NKTR

BVF INC/IL position in NKTR

NEKTAR THERAPEUTICS COM NEW · Health Care

BVF INC/IL reported holding 2,391,075 shares of NKTR (NEKTAR THERAPEUTICS COM NEW) in its Q2 2026 13F filing — a position valued at US$166.9M, representing 4.27% of its reported portfolio and ranking #7 among its reported holdings. BVF INC/IL has disclosed NKTR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)2.39M sh
Reported value held$166.92M
Portfolio Weight4.27%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's NKTR position evolved

BVF INC/IL first disclosed a stake in NKTR in Q3 2025 at 1,276,595 shares (US$72.6M). The position peaked in Q1 2026 at 2,559,595 shares, worth US$184.2M. Across 4 filings, BVF INC/IL increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,391,075 shares valued at US$166.9M — a reduction of -168,520 shares quarter over quarter.. Notable position changes include a 64% increase in Q1 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.28M $72.64M New
Q4 2025 1.56M $65.94M Add
Q1 2026 2.56M $184.16M Add
Q2 2026 2.39M $166.92M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NKTR and 13F data

NKTR (NEKTAR THERAPEUTICS COM NEW) is a Health Care company. 70 other funds we track also report a position in NKTR — the largest reported positions include Two Seas Capital LP (US$202.6M), Vestal Point Capital, LP (US$69.8M), Prosight Management, LP (US$56.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NKTR

All NKTR fund holders →

FAQ

How long has BVF INC/IL held NKTR?

BVF INC/IL has disclosed NKTR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is BVF INC/IL's current position in NKTR?

As of Q2 2026, BVF INC/IL holds 2.39M shares of NKTR (NEKTAR THERAPEUTICS COM NEW), valued at $166.92M, representing 4.27% of its reported portfolio and ranking #7.

Has BVF INC/IL been buying or selling NKTR?

In the latest 13F filing (Q2 2026), BVF INC/IL reduced its position in NKTR. The position peaked in Q1 2026 at 2.56M shares.

Which other funds hold NKTR?

Other major institutional holders of NKTR include Two Seas Capital LP, Vestal Point Capital, LP, Prosight Management, LP, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.